In light of recent revelations surrounding a new intranasal COVID-19 vaccine candidate, there is growing concern that the American public is once again being led into potentially dangerous territory ...

As vaccination rates among children continue to plummet, concerns are rising over the potential for infectious disease to spread rampantly.

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 3.6% in the morning session after JPMorgan added the stock to its ...

Pennsylvania first detected CWD in 2012 in Adams County, and the disease has since spread to all south-central counties, ...

Screening of more than 12,000 Aspergillus fumigatus isolates collected from Dutch hospitals found 15% harbored triazole ...

Moderna’s COVID-19 vaccine has received full FDA approval for use in children at higher risk for severe illness.

Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...

The mRNA technology behind the Pfizer and Moderna vaccines are groundbreaking, but their potential goes way beyond COVID-19.